Green Cross Health
- Home ›
- NZ ›
- Consumer Retailing
Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand. The last earnings update was 174 days ago. More info.
Add to Portfolio Compare Print
GXH Share Price and Events
7 Day Returns
1 Year Returns
GXH Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Green Cross Health (GXH) | 4.5% | 3.5% | 8.3% | -30.4% | -58.8% | -12% |
| Global Consumer Retailing | 1.1% | -0.6% | -1.1% | 9.1% | 19.8% | 18.4% |
| NZ Market | 0.6% | 1.7% | 7.1% | 10.4% | 26.2% | 51.2% |
1 Year Return vs Industry and Market
- GXH underperformed the Consumer Retailing industry which returned 9.1% over the past year.
- GXH underperformed the Market in New Zealand which returned 10.4% over the past year.
Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Green Cross Health
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Green Cross Health.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 1 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 7.1% |
| Perpetual Growth Rate | 10-Year NZ Government Bond Rate | 2.4% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year NZ Govt Bond Rate | 2.4% |
| Equity Risk Premium | S&P Global | 6% |
| Consumer Retailing Unlevered Beta | Simply Wall St/ S&P Global | 0.46 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.458 (1 + (1- 28%) (32.47%)) |
0.709 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
0.8 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.37% + (0.8 * 5.96%) |
7.14% |
Discounted Cash Flow Calculation for NZSE:GXH using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Green Cross Health is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (NZD, Millions) | Source |
Present Value Discounted (@ 7.14%) |
|
|---|---|---|---|
| 2019 | 5.68 | Est @ -54.9% | 5.30 |
| 2020 | 3.54 | Est @ -37.72% | 3.08 |
| 2021 | 2.63 | Est @ -25.69% | 2.14 |
| 2022 | 2.17 | Est @ -17.27% | 1.65 |
| 2023 | 1.93 | Est @ -11.38% | 1.36 |
| 2024 | 1.79 | Est @ -7.26% | 1.18 |
| 2025 | 1.71 | Est @ -4.37% | 1.05 |
| 2026 | 1.67 | Est @ -2.35% | 0.96 |
| 2027 | 1.65 | Est @ -0.93% | 0.89 |
| 2028 | 1.65 | Est @ 0.06% | 0.83 |
| Present value of next 10 years cash flows | NZ$18.45 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= NZ$1.65 × (1 + 2.37%) ÷ (7.14% – 2.37%) |
NZ$35.51 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= NZ$35.51 ÷ (1 + 7.14%)10 |
NZ$17.82 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= NZ$18.45 + NZ$17.82 |
NZ$36.27 |
| Equity Value per Share (NZD) |
= Total value / Shares Outstanding
= NZ$36.27 / 142.81 |
NZ$0.25 |
| Calculation | Result | |
|---|---|---|
| Value per share (NZD) | From above. | NZ$0.25 |
| Current discount | Discount to share price of
NZ$1.17
= -1 x (NZ$1.17 - NZ$0.25) / NZ$0.25 |
-360.7% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Green Cross Health is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Green Cross Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Green Cross Health's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-09-30) in NZD | NZ$0.11 |
| NZSE:GXH Share Price ** | NZSE (2019-05-20) in NZD | NZ$1.17 |
| Global Consumer Retailing Industry PE Ratio | Median Figure of 108 Publicly-Listed Consumer Retailing Companies | 20.18x |
| New Zealand Market PE Ratio | Median Figure of 90 Publicly-Listed Companies | 18.22x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Green Cross Health.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NZSE:GXH Share Price ÷ EPS (both in NZD) = 1.17 ÷ 0.11 |
10.33x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Green Cross Health is good value based on earnings compared to the Global Consumer Retailing industry average.
- Green Cross Health is good value based on earnings compared to the New Zealand market.
Price based on expected Growth
Does
Green Cross Health's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 10.33x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts |
9.7%per year |
| Global Consumer Retailing Industry PEG Ratio | Median Figure of 49 Publicly-Listed Consumer Retailing Companies | 2.09x |
| New Zealand Market PEG Ratio | Median Figure of 66 Publicly-Listed Companies | 1.51x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 10.33x ÷ 9.7% |
1.06x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Green Cross Health is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on
Green Cross Health's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-09-30) in NZD | NZ$0.87 |
| NZSE:GXH Share Price * | NZSE (2019-05-20) in NZD | NZ$1.17 |
| Global Consumer Retailing Industry PB Ratio | Median Figure of 161 Publicly-Listed Consumer Retailing Companies | 1.58x |
| New Zealand Market PB Ratio | Median Figure of 125 Publicly-Listed Companies | 1.55x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NZSE:GXH Share Price ÷ Book Value per Share (both in NZD) = 1.17 ÷ 0.87 |
1.35x |
* Primary Listing of Green Cross Health.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Green Cross Health is good value based on assets compared to the Global Consumer Retailing industry average.
Value checks
We assess Green Cross Health's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Consumer Retailing industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Consumer Retailing industry average (and greater than 0)? (1 check) Green Cross Health has a total score of 3/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Green Cross Health's earnings growth is expected to exceed the low risk savings rate of 2.4%.
Growth vs Market Checks
- Green Cross Health's earnings growth is expected to exceed the New Zealand market average.
- Green Cross Health's revenue growth is expected to exceed the New Zealand market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NZSE:GXH Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts | 9.7% |
| NZSE:GXH Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts | 6.5% |
| Global Consumer Retailing Industry Earnings Growth Rate | Market Cap Weighted Average | 8.4% |
| Global Consumer Retailing Industry Revenue Growth Rate | Market Cap Weighted Average | 3.9% |
| New Zealand Market Earnings Growth Rate | Market Cap Weighted Average | 7% |
| New Zealand Market Revenue Growth Rate | Market Cap Weighted Average | 5.1% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (7 months ago) | See Below |
| Future Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
| Date (Data in NZD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2021-03-31 | 644 | 22 | 1 | |
| 2020-03-31 | 606 | 21 | 1 | |
| 2019-03-31 | 568 | 20 | 1 |
| Date (Data in NZD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-09-30 | 546 | 25 | 16 |
| 2018-06-30 | 535 | 29 | 16 |
| 2018-03-31 | 523 | 33 | 17 |
| 2017-12-31 | 518 | 37 | 17 |
| 2017-09-30 | 509 | 40 | 18 |
| 2017-06-30 | 498 | 35 | 19 |
| 2017-03-31 | 488 | 30 | 20 |
| 2016-12-31 | 480 | 26 | 19 |
| 2016-09-30 | 472 | 23 | 19 |
| 2016-06-30 | 460 | 21 | 18 |
| 2016-03-31 | 448 | 18 | 17 |
| 2015-12-31 | 424 | 17 | 16 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (7 months ago) | See Below |
| Future Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
All data from Green Cross Health Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in NZD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2021-03-31 | 0.16 | 0.16 | 0.16 | 1.00 |
| 2020-03-31 | 0.15 | 0.15 | 0.15 | 1.00 |
| 2019-03-31 | 0.14 | 0.14 | 0.14 | 1.00 |
| Date (Data in NZD Millions) | EPS * |
|---|---|
| 2018-09-30 | 0.11 |
| 2018-06-30 | 0.12 |
| 2018-03-31 | 0.12 |
| 2017-12-31 | 0.12 |
| 2017-09-30 | 0.13 |
| 2017-06-30 | 0.14 |
| 2017-03-31 | 0.14 |
| 2016-12-31 | 0.14 |
| 2016-09-30 | 0.14 |
| 2016-06-30 | 0.13 |
| 2016-03-31 | 0.13 |
| 2015-12-31 | 0.12 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Green Cross Health's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Global market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Global market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Green Cross Health has a total score of 3/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
Past Performance
How has Green Cross Health performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Green Cross Health's year on year earnings growth rate has been positive over the past 5 years.
- Green Cross Health's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Green Cross Health's 1-year earnings growth is negative, it can't be compared to the Global Consumer Retailing industry average.
Earnings and Revenue History
All data from Green Cross Health Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in NZD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-09-30 | 546.33 | 16.16 | 20.88 | |
| 2018-06-30 | 534.62 | 16.47 | 20.74 | |
| 2018-03-31 | 522.91 | 16.78 | 20.60 | |
| 2017-12-31 | 518.32 | 17.35 | 20.29 | |
| 2017-09-30 | 508.92 | 17.92 | 19.99 | |
| 2017-06-30 | 498.28 | 18.78 | 19.83 | |
| 2017-03-31 | 487.65 | 19.64 | 19.67 | |
| 2016-12-31 | 480.01 | 19.44 | 19.64 | |
| 2016-09-30 | 472.37 | 19.23 | 19.62 | |
| 2016-06-30 | 460.04 | 18.13 | 18.92 | |
| 2016-03-31 | 447.70 | 17.04 | 18.23 | |
| 2015-12-31 | 424.19 | 16.41 | 3.16 | |
| 2015-09-30 | 400.69 | 15.78 | -11.90 | |
| 2015-06-30 | 361.58 | 15.10 | 1.42 | |
| 2015-03-31 | 322.48 | 14.43 | 14.74 | |
| 2014-12-31 | 294.12 | 14.66 | 42.08 | |
| 2014-09-30 | 265.77 | 14.89 | 69.41 | |
| 2014-06-30 | 261.86 | 14.96 | 68.38 | |
| 2014-03-31 | 257.95 | 15.03 | 67.35 | |
| 2013-12-31 | 254.96 | 14.54 | 66.99 | |
| 2013-09-30 | 251.98 | 14.05 | 66.62 | |
| 2013-06-30 | 250.22 | 13.53 | 65.62 | |
| 2013-03-31 | 248.47 | 13.01 | 64.62 | |
| 2012-12-31 | 212.63 | 12.45 | 56.61 | |
| 2012-09-30 | 176.79 | 11.88 | 48.60 | |
| 2012-06-30 | 141.17 | 10.91 | 39.17 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Green Cross Health has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Green Cross Health used its assets more efficiently than the Global Consumer Retailing industry average last year based on Return on Assets.
- Green Cross Health's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Green Cross Health's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Consumer Retailing industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Green Cross Health has a total score of 2/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
Health
How is Green Cross Health's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Green Cross Health's finances.
The net worth of a company is the difference between its assets and liabilities.
- Green Cross Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Green Cross Health's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is covered by short term assets, assets are 1.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Green Cross Health Company Filings, last reported 7 months ago.
| Date (Data in NZD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-09-30 | 132.22 | 53.78 | 9.69 |
| 2018-06-30 | 132.22 | 53.78 | 9.69 |
| 2018-03-31 | 128.06 | 49.22 | 10.75 |
| 2017-12-31 | 128.06 | 49.22 | 10.75 |
| 2017-09-30 | 120.42 | 52.42 | 14.70 |
| 2017-06-30 | 120.42 | 52.42 | 14.70 |
| 2017-03-31 | 112.23 | 65.54 | 18.20 |
| 2016-12-31 | 112.23 | 65.54 | 18.20 |
| 2016-09-30 | 104.16 | 65.70 | 14.51 |
| 2016-06-30 | 104.16 | 65.70 | 14.51 |
| 2016-03-31 | 94.14 | 72.48 | 19.92 |
| 2015-12-31 | 94.14 | 72.48 | 19.92 |
| 2015-09-30 | 85.29 | 61.91 | 15.18 |
| 2015-06-30 | 85.29 | 61.91 | 15.18 |
| 2015-03-31 | 99.42 | 38.95 | 23.55 |
| 2014-12-31 | 99.42 | 38.95 | 23.55 |
| 2014-09-30 | 93.97 | 10.45 | 22.80 |
| 2014-06-30 | 93.97 | 10.45 | 22.80 |
| 2014-03-31 | 89.42 | 9.29 | 25.27 |
| 2013-12-31 | 89.42 | 9.29 | 25.27 |
| 2013-09-30 | 83.54 | 14.30 | 21.16 |
| 2013-06-30 | 83.54 | 14.30 | 21.16 |
| 2013-03-31 | 74.89 | 13.08 | 19.83 |
| 2012-12-31 | 74.89 | 13.08 | 19.83 |
| 2012-09-30 | 67.58 | 7.00 | 7.23 |
| 2012-06-30 | 67.58 | 7.00 | 7.23 |
- Green Cross Health's level of debt (40.7%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has increased over the past 5 years (17% vs 40.7% today).
- Debt is well covered by operating cash flow (45.8%, greater than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 13.8x coverage).
Financial health checks
We assess Green Cross Health's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Green Cross Health has a total score of 3/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
Dividends
What is Green Cross Health's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
NZ$2,000 of
Green Cross Health
shares you are expected to receive
NZ$120
in your first year as a dividend.
Dividend Amount
- Green Cross Health's pays a higher dividend yield than the bottom 25% of dividend payers in New Zealand (3.3%).
- Green Cross Health's dividend is above the markets top 25% of dividend payers in New Zealand (5.68%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
| Global Consumer Retailing Industry Average Dividend Yield | Market Cap Weighted Average of 74 Stocks | 2.3% |
| New Zealand Market Average Dividend Yield | Market Cap Weighted Average of 73 Stocks | 3.8% |
| New Zealand Minimum Threshold Dividend Yield | 10th Percentile | 2.2% |
| New Zealand Bottom 25% Dividend Yield | 25th Percentile | 3.3% |
| New Zealand Top 25% Dividend Yield | 75th Percentile | 5.7% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in NZ$) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2021-03-31 | 0.08 | 1.00 |
| 2020-03-31 | 0.08 | 1.00 |
| 2019-03-31 | 0.07 | 1.00 |
| Date (Data in NZ$) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2018-11-27 | 0.070 | 6.377 |
| 2018-05-30 | 0.070 | 4.994 |
| 2017-11-27 | 0.070 | 4.149 |
| 2017-05-24 | 0.070 | 3.354 |
| 2016-11-28 | 0.070 | 2.948 |
| 2016-05-24 | 0.070 | 2.599 |
| 2015-11-24 | 0.070 | 2.658 |
| 2015-05-26 | 0.070 | 3.000 |
| 2014-11-25 | 0.070 | 3.188 |
| 2014-05-27 | 0.070 | 4.128 |
| 2013-11-26 | 0.070 | 5.629 |
| 2013-05-28 | 0.070 | 5.436 |
| 2012-11-28 | 0.040 | 3.235 |
| 2012-05-22 | 0.035 | 3.074 |
| 2011-11-28 | 0.000 | 0.000 |
| 2011-05-27 | 0.000 | 0.000 |
| 2010-06-30 | 0.013 | 3.239 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Green Cross Health has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
- Dividend payments have increased, but Green Cross Health only paid a dividend in the past 9 years.
Current Payout to shareholders
What portion of
Green Cross Health's earnings are
paid
to the shareholders as a dividend.
- Dividends paid are covered by earnings (1.6x coverage).
- Dividends after 3 years are expected to be covered by earnings (1.9x coverage).
Income/ dividend checks
We assess Green Cross Health's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 2.2%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Green Cross Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Green Cross Health has a total score of 4/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
Management
CEO
| TENURE AS CEO | 5.6 years |
CEO Bio
Mr. Grant Clayton Bai has been the Chief Executive Officer of Pharmacy & Medical at Pharmacybrands Limited since October 1, 2013 and served as its General Manager of Pharmacy and also as an Executive of Operations from April 2013 to September 2013.
CEO Compensation
- Insufficient data for Grant to compare compensation growth.
- Insufficient data for Grant to establish whether their remuneration is reasonable compared to companies of similar size in New Zealand.
Management Team Tenure
Average tenure of the Green Cross Health management team in years:
- The tenure for the Green Cross Health management team is about average.
Management Team
Steve Browning
COO & CFO
Mark Smith
Chief Information Officer
1.2 yrs
Grant Bai
Chief Executive Officer of Pharmacy & Medical
5.6 yrs
Alison Van Wyk
Chief Executive Officer of Community Health Division
Jim Greenwood
Company Secretary
Dave Audley
Executive of Information Systems
4.3 yrs
Board of Directors Tenure
Average tenure of the Green Cross Health board of directors in years:
- The tenure for the Green Cross Health board of directors is about average.
Board of Directors
Peter Merton
Chairman
NZ$85K
Ken Orr
Independent Director
NZ$60K
7.2 yrs
Carolyn Steele
Independent Director
NZ$53K
1.9 yrs
John Bagnall
Non-Executive Director
NZ$35K
11.8 yrs
John Bolland
Non-Executive Director
NZ$35K
10.6 yrs
M. Millard
Independent Director
NZ$60K
4.4 yrs
Tony Edwards
Independent Director
NZ$60K
3.8 yrs
Peter Williams
Non-Executive Director
NZ$30K
2 yrs
Mary-Elizabeth Tuck
Alternate Director
6.9 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (NZ$) | Value (NZ$) | |
|---|---|---|---|---|---|---|---|---|---|---|
Management checks
We assess Green Cross Health's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Green Cross Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
News
Simply Wall St News
Is Green Cross Health Limited (NZSE:GXH) An Attractive Dividend Stock?
Dividend paying stocks like Green Cross Health Limited (NZSE:GXH) tend to be popular with investors, and for good reason - some research suggests a significant amount of all stock market returns come from reinvested dividends. … Conclusion To summarise, shareholders should always check that Green Cross Health's dividends are affordable, that its dividend payments are relatively stable, and that it has decent prospects for growing its earnings and dividend. … While we're not hugely bearish on it, overall we think there are potentially better dividend stocks than Green Cross Health out there.
Simply Wall St - – Full articleDoes The Green Cross Health Limited (NZSE:GXH) Share Price Fall With The Market?
Beta is a widely used metric to measure a stock's exposure to market risk (volatility). … Before we go on, it's worth noting that Warren Buffett pointed out in his 2014 letter to shareholders that 'volatility is far from synonymous with risk.' Having said that, beta can still be rather useful. … A stock with a beta greater than one is more sensitive to broader market movements than a stock with a beta of less than one.
Simply Wall St - – Full articleIs Green Cross Health Limited (NZSE:GXH) A Financially Sound Company?
Investors are always looking for growth in small-cap stocks like Green Cross Health Limited (NZSE:GXH), with a market cap of NZ$149m. … Evaluating financial health as part of your investment thesis is. … The following basic checks can help you get a picture of the company's balance sheet strength.
Simply Wall St - – Full articleWhat Does Green Cross Health Limited's (NZSE:GXH) Share Price Indicate?
Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price? … A question to answer is whether Green Cross Health's current trading price of NZ$0.98 reflective of the actual value of the? … Let’s take a look at Green Cross Health’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change
Simply Wall St - – Full articleDoes Green Cross Health Limited's (NZSE:GXH) -9.8% Earnings Drop Reflect A Longer Term Trend?
Today I will examine Green Cross Health Limited's (NZSE:GXH) latest earnings update (30 September 2018) and compare these figures against its performance over the past couple of years, in addition to how the rest of GXH's industry performed. … GXH's trailing twelve-month earnings (from 30 September 2018) of NZ$16m has. … Furthermore, this one-year growth rate has been lower than its average earnings growth rate over the past 5 years of 4.7%, indicating the rate at which GXH is growing has slowed down
Simply Wall St - – Full articleDid You Manage To Avoid Green Cross Health's Painful 61% Share Price Drop?
And over the last year the share price fell 40%, so we doubt many shareholders are delighted. … The falls have accelerated recently, with the share price down 17% in the last three months. … Green Cross Health saw its EPS decline at a compound rate of 1.3% per year, over the last three years.
Simply Wall St - – Full articleDo You Know What Green Cross Health Limited's (NZSE:GXH) P/E Ratio Means?
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). … We'll look at Green Cross Health Limited's (NZSE:GXH) P/E ratio and reflect on what it tells us about the company's share price. … Green Cross Health has a price to earnings ratio of 9.1, based on the last twelve months.
Simply Wall St - – Full articleIs Green Cross Health Limited (NZSE:GXH) A Smart Pick For Income Investors?
Historically, Green Cross Health Limited (NZSE:GXH) has paid dividends to shareholders, and these days it yields 6.4%. … Let's take a look at Green Cross Health in more detail. … View our latest analysis for Green Cross Health
Simply Wall St - – Full articleHow Green Cross Health Limited (NZSE:GXH) Can Impact Your Portfolio Volatility
Some stocks mimic the volatility of the market quite closely, while others demonstrate muted, exagerrated or uncorrelated price movements. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … A stock with a beta greater than one is more sensitive to broader market movements than a stock with a beta of less than one.
Simply Wall St - – Full articleShould You Be Holding Green Cross Health Limited (NZSE:GXH)?
Today I've chosen to put the spotlight on Green Cross Health Limited (NZSE:GXH) due to its excellent fundamentals in more than one area. … that has been a rockstar for income investors, currently trading at an attractive share price
Simply Wall St - – Full articleCompany Info
Description
Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand. The company operates in three segments: Pharmacy Services, Medical Services, and Community Health. The Pharmacy Services segment provides pharmacy services in the areas of beauty services, medicine management, vaccination, diagnostic and health checks, smoking cessation, weight management, health and medical equipment, travel services, and women's health through consolidated stores, equity accounted investments, and franchise stores. It operates a network of approximately 330 Unichem and Life pharmacies. The Medical Services segment operates owned and equity accounted medical centers; and offers support services provided to these medical centers, as well as medical centers outside the company. The Community Health segment provides services direct to the community to support independent living. The company was formerly known as Pharmacybrands Limited and changed its name to Green Cross Health Limited in April 2014. Green Cross Health Limited was incorporated in 1999 and is based in Auckland, New Zealand.
Details
| Name: | Green Cross Health Limited |
| GXH | |
| Exchange: | NZSE |
| Founded: | 1999 |
| NZ$165,661,640 | |
| 142,811,759 | |
| Website: | http://www.greencrosshealth.co.nz |
| Address: |
Green Cross Health Limited Millennium Centre, Ground Floor, Building B, Auckland, 1542, New Zealand |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NZSE | GXH | Ordinary Shares | New Zealand Stock Exchange | NZ | NZD | 01. Oct 2009 |
Number of employees
Current staff
Industry
| Drug Retail | |
| Consumer Retailing |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/05/20 10:35 |
| End of day share price update: | 2019/05/20 00:00 |
| Last estimates confirmation: | 2019/05/05 |
| Last earnings filing: | 2018/11/27 |
| Last earnings reported: | 2018/09/30 |
| Last annual earnings reported: | 2018/03/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
